Low‐grade systemic inflammation stimulates microglial turnover and accelerates the onset of Alzheimer's‐like pathology
Glia · 2024
DOI: 10.1002/glia.24532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, 2024. Verfasst von Monica Guerrero-Carrasco und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, University of Southampton, Southampton General Hospital, Southampton, UK. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease, Inflammation, Mice, Transgenic. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Gerald Kerkut Charitable Trust.
Themen: Demenz
Abstract (Originalsprache)
Several in vivo studies have shown that systemic inflammation, mimicked by LPS, triggers an inflammatory response in the CNS, driven by microglia, characterized by an increase in inflammatory cytokines and associated sickness behavior. However, most studies induce relatively high systemic inflammation, not directly compared with the more common low‐grade inflammatory events experienced in humans during the life course. Using mice, we investigated the effects of low‐grade systemic inflammation during an otherwise healthy early life, and how this may precondition the onset and severity of Alzheimer's disease (AD)‐like pathology. Our results indicate that low‐grade systemic inflammation induces sub‐threshold brain inflammation and promotes microglial proliferation driven by the CSF1R pathway, contrary to the effects caused by high systemic inflammation. In addition, repeated systemic challenges with low‐grade LPS induce disease‐associated microglia. Finally, using an inducible model of AD‐like pathology (Line 102 mice), we observed that preconditioning with repeated doses of low‐grade systemic inflammation, prior to APP induction, promotes a detrimental effect later in life, leading to an increase in Aβ accumulation and disease‐associated microglia. These results support the notion that episodic low‐grade systemic inflammation has the potential to influence the onset and severity of age‐related neurological disorders, such as AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, University of Southampton, Southampton General Hospital, Southampton, UK.
- Institute for Life Sciences (IfLS), University of Southampton, Southampton, UK.
ORCID-Profile: Monica Guerrero-Carrasco, Diego Gomez-Nicola
Förderung
- Medical Research Council
- Gerald Kerkut Charitable Trust
Zitieren
APA
Guerrero-Carrasco, M., Targett, I., Olmos-Alonso, A., Vargas-Caballero, M., & Gomez-Nicola, D. (2024). Low‐grade systemic inflammation stimulates microglial turnover and accelerates the onset of Alzheimer's‐like pathology. Glia. https://doi.org/10.1002/glia.24532
Vancouver
Guerrero-Carrasco M, Targett I, Olmos-Alonso A, Vargas-Caballero M, Gomez-Nicola D. Low‐grade systemic inflammation stimulates microglial turnover and accelerates the onset of Alzheimer's‐like pathology. Glia. 2024. doi:10.1002/glia.24532
BibTeX
@article{GuerreroCarrasco2024,
author = {Guerrero-Carrasco, Monica and Targett, Imogen and Olmos-Alonso, Adrian and Vargas-Caballero, Mariana and Gomez-Nicola, Diego},
title = {Low‐grade systemic inflammation stimulates microglial turnover and accelerates the onset of Alzheimer's‐like pathology},
journal = {Glia},
year = {2024},
doi = {10.1002/glia.24532}
}
EUVIMED